Validation of an Estonian version of the Parkinson's Disease Questionnaire (PDQ-39).
Identifieur interne : 000F96 ( PubMed/Corpus ); précédent : 000F95; suivant : 000F97Validation of an Estonian version of the Parkinson's Disease Questionnaire (PDQ-39).
Auteurs : Ulle Krikmann ; Pille Taba ; Taavi Lai ; Toomas AsserSource :
- Health and quality of life outcomes [ 1477-7525 ] ; 2008.
English descriptors
- KwdEn :
- Activities of Daily Living, Aged, Aged, 80 and over, Estonia, Female, Focus Groups, Humans, Male, Middle Aged, Parkinson Disease (classification), Parkinson Disease (psychology), Patient Acceptance of Health Care (psychology), Patient Acceptance of Health Care (statistics & numerical data), Pilot Projects, Psychometrics (methods), Quality of Life, Reproducibility of Results, Severity of Illness Index, Social Support, Surveys and Questionnaires, Translations.
- MESH :
- geographic : Estonia.
- classification : Parkinson Disease.
- methods : Psychometrics.
- psychology : Parkinson Disease, Patient Acceptance of Health Care.
- statistics & numerical data : Patient Acceptance of Health Care.
- Activities of Daily Living, Aged, Aged, 80 and over, Female, Focus Groups, Humans, Male, Middle Aged, Pilot Projects, Quality of Life, Reproducibility of Results, Severity of Illness Index, Social Support, Surveys and Questionnaires, Translations.
Abstract
Diagnosis and management of Parkinson's disease (PD) rely heavily on evaluation of clinical symptoms and patients' subjective perception of their condition. The purpose of this study was to evaluate the validity, acceptability, and reliability of the Estonian version of the 39-question Parkinson 's disease Questionnaire (PDQ-39).
DOI: 10.1186/1477-7525-6-23
PubMed: 18364047
Links to Exploration step
pubmed:18364047Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Validation of an Estonian version of the Parkinson's Disease Questionnaire (PDQ-39).</title><author><name sortKey="Krikmann, Ulle" sort="Krikmann, Ulle" uniqKey="Krikmann U" first="Ulle" last="Krikmann">Ulle Krikmann</name><affiliation><nlm:affiliation>Department of Neurology and Neurosurgery, University of Tartu, Tartu 51014, Estonia. ylle.krikmann@kliinikum.ee</nlm:affiliation></affiliation></author><author><name sortKey="Taba, Pille" sort="Taba, Pille" uniqKey="Taba P" first="Pille" last="Taba">Pille Taba</name></author><author><name sortKey="Lai, Taavi" sort="Lai, Taavi" uniqKey="Lai T" first="Taavi" last="Lai">Taavi Lai</name></author><author><name sortKey="Asser, Toomas" sort="Asser, Toomas" uniqKey="Asser T" first="Toomas" last="Asser">Toomas Asser</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2008">2008</date><idno type="RBID">pubmed:18364047</idno><idno type="pmid">18364047</idno><idno type="doi">10.1186/1477-7525-6-23</idno><idno type="wicri:Area/PubMed/Corpus">000F96</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000F96</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Validation of an Estonian version of the Parkinson's Disease Questionnaire (PDQ-39).</title><author><name sortKey="Krikmann, Ulle" sort="Krikmann, Ulle" uniqKey="Krikmann U" first="Ulle" last="Krikmann">Ulle Krikmann</name><affiliation><nlm:affiliation>Department of Neurology and Neurosurgery, University of Tartu, Tartu 51014, Estonia. ylle.krikmann@kliinikum.ee</nlm:affiliation></affiliation></author><author><name sortKey="Taba, Pille" sort="Taba, Pille" uniqKey="Taba P" first="Pille" last="Taba">Pille Taba</name></author><author><name sortKey="Lai, Taavi" sort="Lai, Taavi" uniqKey="Lai T" first="Taavi" last="Lai">Taavi Lai</name></author><author><name sortKey="Asser, Toomas" sort="Asser, Toomas" uniqKey="Asser T" first="Toomas" last="Asser">Toomas Asser</name></author></analytic><series><title level="j">Health and quality of life outcomes</title><idno type="eISSN">1477-7525</idno><imprint><date when="2008" type="published">2008</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Activities of Daily Living</term><term>Aged</term><term>Aged, 80 and over</term><term>Estonia</term><term>Female</term><term>Focus Groups</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Parkinson Disease (classification)</term><term>Parkinson Disease (psychology)</term><term>Patient Acceptance of Health Care (psychology)</term><term>Patient Acceptance of Health Care (statistics & numerical data)</term><term>Pilot Projects</term><term>Psychometrics (methods)</term><term>Quality of Life</term><term>Reproducibility of Results</term><term>Severity of Illness Index</term><term>Social Support</term><term>Surveys and Questionnaires</term><term>Translations</term></keywords><keywords scheme="MESH" type="geographic" xml:lang="en"><term>Estonia</term></keywords><keywords scheme="MESH" qualifier="classification" xml:lang="en"><term>Parkinson Disease</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Psychometrics</term></keywords><keywords scheme="MESH" qualifier="psychology" xml:lang="en"><term>Parkinson Disease</term><term>Patient Acceptance of Health Care</term></keywords><keywords scheme="MESH" qualifier="statistics & numerical data" xml:lang="en"><term>Patient Acceptance of Health Care</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Activities of Daily Living</term><term>Aged</term><term>Aged, 80 and over</term><term>Female</term><term>Focus Groups</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Pilot Projects</term><term>Quality of Life</term><term>Reproducibility of Results</term><term>Severity of Illness Index</term><term>Social Support</term><term>Surveys and Questionnaires</term><term>Translations</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Diagnosis and management of Parkinson's disease (PD) rely heavily on evaluation of clinical symptoms and patients' subjective perception of their condition. The purpose of this study was to evaluate the validity, acceptability, and reliability of the Estonian version of the 39-question Parkinson 's disease Questionnaire (PDQ-39).</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">18364047</PMID><DateCreated><Year>2008</Year><Month>04</Month><Day>25</Day></DateCreated><DateCompleted><Year>2008</Year><Month>04</Month><Day>30</Day></DateCompleted><DateRevised><Year>2017</Year><Month>02</Month><Day>20</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1477-7525</ISSN><JournalIssue CitedMedium="Internet"><Volume>6</Volume><PubDate><Year>2008</Year><Month>Mar</Month><Day>25</Day></PubDate></JournalIssue><Title>Health and quality of life outcomes</Title><ISOAbbreviation>Health Qual Life Outcomes</ISOAbbreviation></Journal><ArticleTitle>Validation of an Estonian version of the Parkinson's Disease Questionnaire (PDQ-39).</ArticleTitle><Pagination><MedlinePgn>23</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1186/1477-7525-6-23</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Diagnosis and management of Parkinson's disease (PD) rely heavily on evaluation of clinical symptoms and patients' subjective perception of their condition. The purpose of this study was to evaluate the validity, acceptability, and reliability of the Estonian version of the 39-question Parkinson 's disease Questionnaire (PDQ-39).</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Study subjects were approached during their regular clinic follow-up visits. 104 patients consented to the study and 81 completed questionnaires were used for subsequent testing of psychometric characteristics, validity and reliability.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The content validity was assessed through qualitative content analysis during the pilot study. The patients indicated that the questions were relevant to measure the quality of life of people with PD. The analysis of means showed that the ceiling and floor effects of domain results were within the limits of 15% of Summary Index and of all domains except Stigma, Social Support and Communication where the ceiling effect was 16% to 24% of the responses. Convergent validity was interpreted through correlation between disease severity and PDQ-39 domains. There was a statistically significant difference between the domain scores in patients with mild versus moderate PD in domains of Mobility, ADL, and Communication but not for Stigma, Social Support and Cognition. The reliability was good, Cronbach alpha for all domains and summary index was over 0.8 and item-test correlations between domains and summary index ranged from 0.56 to 0.83.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The psychometric characteristics of an Estonian version of the PDQ-39 were satisfactory. The results of this study were comparable to the results of previous validation studies in other cultural settings in UK, USA, Canada, Spain and Italy. The Estonian version of the PDQ-39 is an acceptable, valid and reliable instrument for quality of life measurement in PD patients.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Krikmann</LastName><ForeName>Ulle</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>Department of Neurology and Neurosurgery, University of Tartu, Tartu 51014, Estonia. ylle.krikmann@kliinikum.ee</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Taba</LastName><ForeName>Pille</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Lai</LastName><ForeName>Taavi</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Asser</LastName><ForeName>Toomas</ForeName><Initials>T</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D023361">Validation Studies</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2008</Year><Month>03</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Health Qual Life Outcomes</MedlineTA><NlmUniqueID>101153626</NlmUniqueID><ISSNLinking>1477-7525</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Neurology. 1967 May;17(5):427-42</RefSource><PMID Version="1">6067254</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Neurol Neurosurg Psychiatry. 1997 Jan;62(1):104</RefSource><PMID Version="1">9010413</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Age Ageing. 1995 Nov;24(6):505-9</RefSource><PMID Version="1">8588541</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Neurol Neurosurg Psychiatry. 1988 Jun;51(6):745-52</RefSource><PMID Version="1">2841426</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Epidemiol. 2003 Sep;56(9):843-7</RefSource><PMID Version="1">14505768</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Value Health. 2005 Mar-Apr;8(2):94-104</RefSource><PMID Version="1">15804318</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Qual Life Res. 2005 Mar;14(2):565-9</RefSource><PMID Version="1">15892447</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Qual Life Res. 2002 May;11(3):193-205</RefSource><PMID Version="1">12074258</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Health Econ. 1993 Oct;2(3):217-27</RefSource><PMID Version="1">8275167</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Epilepsia. 2001 Aug;42(8):1061-73</RefSource><PMID Version="1">11554894</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Psychiatr Res. 1975 Nov;12(3):189-98</RefSource><PMID Version="1">1202204</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMJ. 2000 Jul 1;321(7252):21-2</RefSource><PMID Version="1">10875828</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Qual Life Res. 1995 Jun;4(3):241-8</RefSource><PMID Version="1">7613534</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Qual Life Res. 2001;10(2):159-63</RefSource><PMID Version="1">11642686</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Acta Neurol Scand. 1976 Feb;53(2):81-102</RefSource><PMID Version="1">1266565</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Parkinsonism Relat Disord. 2005 Aug;11(5):297-304</RefSource><PMID Version="1">15886043</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Qual Life Res. 1999 Jun;8(4):345-50</RefSource><PMID Version="1">10472167</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Qual Life Res. 1994 Dec;3(6):403-12</RefSource><PMID Version="1">7866358</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Neurol. 1998 May;245 Suppl 1:S34-8</RefSource><PMID Version="1">9617722</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Acta Neurol Scand. 2002 Nov;106(5):276-81</RefSource><PMID Version="1">12371921</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Pharmacoeconomics. 1999 Feb;15(2):157-65</RefSource><PMID Version="1">10351189</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Psychol Bull. 1955 Jul;52(4):281-302</RefSource><PMID Version="1">13245896</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000203" MajorTopicYN="N">Activities of Daily Living</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004957" MajorTopicYN="N" Type="Geographic">Estonia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017144" MajorTopicYN="N">Focus Groups</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010300" MajorTopicYN="Y">Parkinson Disease</DescriptorName><QualifierName UI="Q000145" MajorTopicYN="N">classification</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010342" MajorTopicYN="N">Patient Acceptance of Health Care</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics & numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010865" MajorTopicYN="N">Pilot Projects</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011594" MajorTopicYN="N">Psychometrics</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="Y">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012944" MajorTopicYN="N">Social Support</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="Y">Surveys and Questionnaires</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014177" MajorTopicYN="N">Translations</DescriptorName></MeshHeading></MeshHeadingList><OtherID Source="NLM">PMC2335093</OtherID></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2007</Year><Month>07</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2008</Year><Month>03</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2008</Year><Month>3</Month><Day>28</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2008</Year><Month>5</Month><Day>1</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2008</Year><Month>3</Month><Day>28</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">18364047</ArticleId><ArticleId IdType="pii">1477-7525-6-23</ArticleId><ArticleId IdType="doi">10.1186/1477-7525-6-23</ArticleId><ArticleId IdType="pmc">PMC2335093</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000F96 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 000F96 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Canada
|area= ParkinsonCanadaV1
|flux= PubMed
|étape= Corpus
|type= RBID
|clé= pubmed:18364047
|texte= Validation of an Estonian version of the Parkinson's Disease Questionnaire (PDQ-39).
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:18364047" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a ParkinsonCanadaV1
| This area was generated with Dilib version V0.6.29. |  |